Portal Biotech Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $11M

  • Investors
  • 8

Portal Biotech General Information

Description

Operator of a biotechnology company intended to develop biosensing technology. The company utilizes bioengineered nanopores to analyze single-cell proteins and metabolites with unparalleled precision, enabling life science markets to get alternatives for their critical unmet needs.

Contact Information

Website
www.portalbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Scale Space
  • 58 Wood Lane
  • London W12 7RZ
  • England, United Kingdom
Primary Industry
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Scale Space
  • 58 Wood Lane
  • London W12 7RZ
  • England, United Kingdom

Portal Biotech Timeline

2022202320242025
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Portal Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 15-Jul-2022 $11M Completed Generating Revenue
1. Early Stage VC 16-Jul-2021 Completed Startup
To view Portal Biotech’s complete valuation and funding history, request access »

Portal Biotech Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
B2 Ordinary
B Ordinary
To view Portal Biotech’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Portal Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to develop biosensing technology. The company utilizes bioengineered nanopo
Biotechnology
London, United Kingdom
25 As of 2024

Branford, CT
 

Uppsala, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Portal Biotech Competitors (3)

One of Portal Biotech’s 3 competitors is Quantum-Si, a Formerly VC-backed company based in Branford, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Quantum-Si Formerly VC-backed Branford, CT
Olink Proteomics Formerly PE-Backed Uppsala, Sweden
Nautilus Biotechnology Formerly VC-backed Seattle, WA
You’re viewing 3 of 3 competitors. Get the full list »

Portal Biotech Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Portal Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202313202-D0 Systems and methods for nanopore-based analyte detection Inactive 30-Aug-2023
US-20240201165-A1 Nanopore-based analysis of analytes Active 28-Oct-2022
AU-2023366631-A1 Nanopore-based analysis of proteins Pending 28-Oct-2022
US-12235260-B2 Nanopore-based analysis of analytes Active 28-Oct-2022 G01N33/48721

Portal Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Portal Biotech Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
8VC Venture Capital Minority
Amino Collective Venture Capital Minority
ANIMO Ventures Venture Capital Minority
Outsized Ventures Venture Capital Minority
Pillar VC Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Portal Biotech FAQs

  • When was Portal Biotech founded?

    Portal Biotech was founded in 2021.

  • Where is Portal Biotech headquartered?

    Portal Biotech is headquartered in London, United Kingdom.

  • What is the size of Portal Biotech?

    Portal Biotech has 25 total employees.

  • What industry is Portal Biotech in?

    Portal Biotech’s primary industry is Biotechnology.

  • Is Portal Biotech a private or public company?

    Portal Biotech is a Private company.

  • What is the current valuation of Portal Biotech?

    The current valuation of Portal Biotech is .

  • What is Portal Biotech’s current revenue?

    The current revenue for Portal Biotech is .

  • How much funding has Portal Biotech raised over time?

    Portal Biotech has raised $11.7M.

  • Who are Portal Biotech’s investors?

    8VC, Amino Collective, ANIMO Ventures, Outsized Ventures, and Pillar VC are 5 of 8 investors who have invested in Portal Biotech.

  • Who are Portal Biotech’s competitors?

    Quantum-Si, Olink Proteomics, and Nautilus Biotechnology are competitors of Portal Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »